Valuation (83%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 5.58 | 5.79 |
| PEG Ratio (TTM) | 0.69 | -0.34 |
| P/S Ratio (TTM) | 0.72 | 1.32 |
| P/B Ratio (TTM) | 0.84 | 1.62 |
| P/FCF Ratio (TTM) | 5.95 | 9.06 |
| Price to 5YR AVG Earnings Ratio | -41.19 | 4.08 |
| Price to 5YR AVG FCF Ratio | 5.52 | 10.50 |
Profitability (50%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 9.37% | 13.56% |
| ROE (TTM) | 15.58% | 22.87% |
| Net Profit Margin (TTM) | 12.93% | 16.17% |
| ROIC 5YR AVG | 22.49% | 31.46% |
Growth (43%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 91.87% | -320.07% | -163.59% |
| Revenue | -3.41% | -13.23% | 1.64% |
| Net Income | 87.80% | -299.14% | -135.73% |
| Cash Flow | 725.55% | 1,424.65% | 900.61% |
Health (63%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 2.49 | 2.91 |
| Quick Ratio (TTM) | 1.92 | 2.28 |
| D/E Ratio (TTM) | 0.09 | 0.15 |
| Interest Coverage (TTM) | 9.43 | 21.99 |
| Piotroski F-Score | 6 | 6 |
| Altman Z-Score | 2.56 | 3.98 |
| LTL to 5YR AVG FCF | 0.56 | 0.97 |
| Shares Outstanding Growth 5YR AVG | 5.32% | 4.43% |